• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

选择低水溶性药物的粒径分布 - 数学模型。

Selecting the particle size distribution for drugs with low water solubility - mathematical model.

机构信息

The Selim and Rachel Benin School of Computer Science and Engineering, The Hebrew University of Jerusalem, Israel.

出版信息

Drug Dev Ind Pharm. 2012 Aug;38(8):940-51. doi: 10.3109/03639045.2011.634808. Epub 2012 Feb 10.

DOI:10.3109/03639045.2011.634808
PMID:22320660
Abstract

PURPOSE

To introduce guidelines in selecting the particle size distribution (n(0), cm(-1)) that will guarantee optimal oral absorption for drugs with low solubility.

METHODS

Unlike other multi-compartmental models the gastrointestinal tract is modeled as a continuous tube with spatially varying properties. The transport through the intestinal lumen is described using the dispersion model. The model accounts for the dissolution of poly-dispersed powders.

RESULTS

The model was used to examine the sensitivity of the absorption on permeability (P) and water solubility (C(s)) following administration in different log-normal powders. The absorption exhibits inverse sigmoidal dependence on the mean particle size (r(m), µm) regardless of the administrated dose or drug properties. Thus, there is an optimal r(m) that maximizes the benefit-cost ratio of the formulation; finer particles do not improve the absorption while coarser particles decrease it. Using the model we find that the optimal r(m) depends mainly on the drug C(s) and on the geometrical standard deviation (gSTD).

CONCLUSIONS

The results of this work provide the formulator with guidelines to select both r(m) and gSTD that guarantee optimal absorption.

摘要

目的

介绍用于选择粒径分布(n(0),cm(-1))的指南,以保证低溶解度药物的最佳口服吸收。

方法

与其他多隔室模型不同,胃肠道被建模为具有空间变化特性的连续管。使用弥散模型描述肠腔中的传输。该模型考虑了多分散粉末的溶解。

结果

该模型用于研究在不同对数正态粉末中给药后,吸收对通透性(P)和水溶解度(C(s))的敏感性。吸收表现出与平均粒径(r(m),µm)的逆西格玛依赖性,而与给药剂量或药物性质无关。因此,存在一个最佳的 r(m),它使配方的收益成本比最大化;更细的颗粒不会改善吸收,而更粗的颗粒则会降低吸收。使用该模型,我们发现最佳的 r(m)主要取决于药物 C(s)和几何标准偏差(gSTD)。

结论

这项工作的结果为制剂师提供了指南,以选择保证最佳吸收的 r(m)和 gSTD。

相似文献

1
Selecting the particle size distribution for drugs with low water solubility - mathematical model.选择低水溶性药物的粒径分布 - 数学模型。
Drug Dev Ind Pharm. 2012 Aug;38(8):940-51. doi: 10.3109/03639045.2011.634808. Epub 2012 Feb 10.
2
In silico predictions of gastrointestinal drug absorption in pharmaceutical product development: application of the mechanistic absorption model GI-Sim.在药物产品开发中的胃肠道药物吸收的计算预测:机制吸收模型 GI-Sim 的应用。
Eur J Pharm Sci. 2013 Jul 16;49(4):679-98. doi: 10.1016/j.ejps.2013.05.019. Epub 2013 May 29.
3
Fast-dissolving microparticles fail to show improved oral bioavailability.速溶微粒未能显示出改善的口服生物利用度。
J Pharm Pharmacol. 2006 Oct;58(10):1319-26. doi: 10.1211/jpp.58.10.0004.
4
Possible reduction of effective thickness of intestinal unstirred water layer by particle drifting effect.颗粒漂流效应对肠道非搅动水层有效厚度的可能降低作用。
Int J Pharm. 2010 Mar 15;387(1-2):103-9. doi: 10.1016/j.ijpharm.2009.12.014. Epub 2009 Dec 16.
5
Enhancement of the dissolution rate and oral absorption of a poorly water soluble drug by formation of surfactant-containing microparticles.通过形成含表面活性剂的微粒提高难溶性药物的溶出速率和口服吸收。
Int J Pharm. 2006 Jul 6;317(1):61-8. doi: 10.1016/j.ijpharm.2006.03.001. Epub 2006 May 2.
6
A strategy for preclinical formulation development using GastroPlus as pharmacokinetic simulation tool and a statistical screening design applied to a dog study.一种使用GastroPlus作为药代动力学模拟工具的临床前制剂开发策略以及应用于犬类研究的统计筛选设计。
Eur J Pharm Sci. 2006 Jan;27(1):91-9. doi: 10.1016/j.ejps.2005.08.011. Epub 2005 Oct 10.
7
Drug dissolution: significance of physicochemical properties and physiological conditions.药物溶解:物理化学性质和生理条件的重要性
Drug Discov Today. 2013 Dec;18(23-24):1173-84. doi: 10.1016/j.drudis.2013.08.013. Epub 2013 Sep 13.
8
Theoretical comparison of hydrodynamic diffusion layer models used for dissolution simulation in drug discovery and development.药物研发中用于溶出模拟的流体动力学扩散层模型的理论比较。
Int J Pharm. 2008 Nov 3;363(1-2):73-7. doi: 10.1016/j.ijpharm.2008.07.002. Epub 2008 Jul 15.
9
Rate-limiting steps of oral absorption for poorly water-soluble drugs in dogs; prediction from a miniscale dissolution test and a physiologically-based computer simulation.犬体内难溶性药物口服吸收的限速步骤;基于微型溶出试验和生理计算机模拟的预测
Pharm Res. 2008 Oct;25(10):2334-44. doi: 10.1007/s11095-008-9637-9. Epub 2008 Jun 17.
10
Forecasting in vivo oral absorption and food effect of micronized and nanosized aprepitant formulations in humans.预测人体口服米氮平和纳米阿瑞匹坦制剂的体内吸收和食物效应。
Eur J Pharm Biopharm. 2010 Sep;76(1):95-104. doi: 10.1016/j.ejpb.2010.05.009. Epub 2010 Jun 1.

引用本文的文献

1
Advances in Modeling Approaches for Oral Drug Delivery: Artificial Intelligence, Physiologically-Based Pharmacokinetics, and First-Principles Models.口服药物递送建模方法的进展:人工智能、基于生理的药代动力学和第一性原理模型
Pharmaceutics. 2024 Jul 24;16(8):978. doi: 10.3390/pharmaceutics16080978.
2
Model-based optimization of controlled release formulation of levodopa for Parkinson's disease.基于模型的帕金森病左旋多巴控释制剂的优化。
Sci Rep. 2023 Sep 22;13(1):15869. doi: 10.1038/s41598-023-42878-5.
3
Projection of Target Drug Particle Size in Oral Formulations Using the Refined Developability Classification System (rDCS).
使用改进的可开发性分类系统(rDCS)预测口服制剂中目标药物的粒径
Pharmaceutics. 2023 Jul 8;15(7):1909. doi: 10.3390/pharmaceutics15071909.